Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies

Abstract Background Pneumocystis jirovecii pneumonia (PcP) is an opportunistic infection associated with immunocompromised patients. The development of novel immunotherapies has promoted the incidence of PcP. This study describes the clinical course and outcome of PcP in chimeric antigen receptor (C...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Cheng Zu, Wenxiao Li, Mingming Zhang, Yetian Dong, Shan Fu, Jingjing Feng, Ruimin Hong, He Huang, Yongxian Hu, Junwei Su
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2024-10-01
Цуврал:	BMC Infectious Diseases
Нөхцлүүд:	Pneumocystis pneumonia Hematological malignancy Adoptive cell therapy Primary prophylaxis
Онлайн хандалт:	https://doi.org/10.1186/s12879-024-09893-x
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!